On the stock market since 2021, it operates in the world of health and science. It has 993 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 11% a year over the last 4 years. Every year shown ended in profit.
The gap is $107.2M. In times of high interest rates, a gap like that can squeeze a company.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Bets Against the Stock: The number of investors betting on a fall stands out.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 3 years, sales grew about 9% a year on average.
The company’s market value is 83 times its annual profit. Even a small disappointment could hit the price hard.
The weight of investors positioned for a fall can be felt in the market. Council score: 2/10.
The price action doesn’t yet back an upward turn. Council score: 2/10.
On our five-subject report card, MEDOF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: MEDOF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.